Compounds > rubimaillin
Page last updated: 2024-09-03

rubimaillin and 1,3,6-trihydroxy-2-methyl-9,10-anthraquinone

rubimaillin has been researched along with 1,3,6-trihydroxy-2-methyl-9,10-anthraquinone in 1 studies

Compound Research Comparison

Studies
(rubimaillin)		Trials
(rubimaillin)		Recent Studies (post-2010)
(rubimaillin)		Studies
(1,3,6-trihydroxy-2-methyl-9,10-anthraquinone)		Trials
(1,3,6-trihydroxy-2-methyl-9,10-anthraquinone)		Recent Studies (post-2010) (1,3,6-trihydroxy-2-methyl-9,10-anthraquinone)
46033502

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cheng, TH; Chung, MI; Jou, SJ; Ko, FN; Lin, CN; Teng, CM1

Other Studies

1 other study(ies) available for rubimaillin and 1,3,6-trihydroxy-2-methyl-9,10-anthraquinone

ArticleYear
Antiplatelet constituents of formosan Rubia akane.
    Journal of natural products, 1994, Volume: 57, Issue:2

    Topics: Animals; Arachidonic Acid; Collagen; In Vitro Techniques; Magnetic Resonance Spectroscopy; Mass Spectrometry; Plants, Medicinal; Platelet Aggregation; Platelet Aggregation Inhibitors; Rabbits; Spectrophotometry, Infrared; Spectrophotometry, Ultraviolet; Taiwan; Thrombin

1994